#wegovy
#wegovy
[ follow ]
#novo-nordisk #semaglutide #glp-1 #obesity-treatment #fda-approval #drug-pricing #glp-1-drugs #oral-glp-1 #ozempic
from24/7 Wall St.
1 month agoEli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader
Lilly's fourth quarter revenue reached $19.29 billion, up 42.6% year-over-year, powered almost entirely by two products. Mounjaro generated $7.41 billion, up 110%, while Zepbound added $4.26 billion, up 123%.
Medicine
Healthcare
fromFast Company
2 months agoHims & Hers stock price is surging today. A surprising rumor about Novo Nordisk is the reason why
Hims & Hers stock surges on reports of a deal with Novo Nordisk to sell GLP-1 weight-loss drugs including Wegovy, reversing their recent legal conflict over compounded versions.
fromwww.npr.org
4 months agoU.S. regulators approve Wegovy pill for weight loss
U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration's approval handed drugmaker Novo Nordisk an edge over rival Eli Lilly in the race to market an obesity pill. Lilly's oral drug, orforglipron, is still under review. Both pills are GLP-1 drugs that work like widely used injectables to mimic a natural hormone that controls appetite and feelings of fullness.
Medicine
Wellness
fromLondon Business News | Londonlovesbusiness.com
8 months agoPrioritising employee wellbeing: How weight management supports a productive workforce - London Business News | Londonlovesbusiness.com
Supporting employee weight management improves energy, focus, reduces health risks, lowers absenteeism, and enhances productivity and cost-efficiency.
[ Load more ]